February 3, 2025 Living with Huntington’s Disease: A Conversation on Advocacy, Mental Health, and Self-Care I recently had the privilege of sitting down with Lauren Holder, Producer and Host of the Help 4 HD podcast, who is also a...
February 1, 2025 Increased discoverability of rare disease datasets through knowledge graph integration Healthcare datasets can be used for many different purposes in the pursuit of...
February 1, 2025 Accelerating Parkinson’s Disease Drug Development with Federated Learning Approaches Parkinson’s Disease is a progressive neurodegenerative disorder afflicting almost 12 million people...
February 1, 2025 Understanding what aspects of Parkinson’s disease matter most to patients and families Understanding what matters to people with Parkinson’s and their family is essential to derive relevant clinical outcome measures
January 31, 2025 Integrating Complex In Vitro Models Into the Regulatory Pipeline C-Path has developed a framework to support FDA qualification of CIVMs for use in regulatory submissions...
January 28, 2025 TRxA Funding Opportunities 2025 On January 28, C-Path’s Translational Therapeutics Accelerator (TRxA)...
January 28, 2025-January 29, 2025 2025 CRDSA Summit Recordings Available Featuring a keynote address by C-Path CEO Klaus Romero, the first day of...
January 23, 2025 C-Path Announces Jennifer Kendra as New Vice President of Strategic Partnerships TUCSON, Ariz., January 23, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Jennifer Kendra as...
January 21, 2025 Save the Date: CGIC Returns to D.C. this September We are thrilled to invite you to the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC)...
January 17, 2025 CP-RND ALS Public-Private Partnership Public Forum A public forum for stakeholders Critical Path Institute's (C-Path) Critical Path for Rare and Neurodegenerative Diseases...
